News

Asia-Pacific's First and World-Leading

Respiratory Organoid Platform

Breakthrough in Influenza Defense: Organoid-based Studies Reveal Cross-Protective NA Antibodies Against H5N1 Viruses

  • |Publications
  • |2026-07-10
  • |BiomOrgan
Share:

A summary of the latest research led by Prof. Zhou Jie and collaborators at The University of Hong Kong and St. Jude Children’s Research Hospital, published in Nature Communications on June 8, 2026.


This study explores a newly identified cross‑protective immune mechanism against emerging H5N1 influenza viruses, demonstrating how advanced human respiratory organoid platforms enable deeper insights into influenza immunity and support the development of NA‑targeted vaccines and therapeutics.


Summary available below.


For collaboration inquiries: bd@biomorgan.hk



Recommended News